Category: Uncategorized

Administrative Healthcare Reform: Ministry of Health Responds to Voters on Streamlining Health Insurance Referral Procedures and Expanding Direct Referral Eligibility

13/08/2026 Published by Pharma Biz

Key Development The Ministry of Health (MOH) of Vietnam has officially issued an administrative response to petitions submitted by voters... Read more

Tags: #Vietnam

Beating the Heat Without Spiking Your Blood Sugar

13/08/2026 Published by Pharma Biz

On a hot day, a cold smoothie or a glass of fresh fruit juice is hard to resist — refreshing,... Read more

Category: Uncategorized

Tags: #Personal Health

Stroke or Low Blood Sugar? Mistaking One for the Other Can Lead to the Wrong Response

13/08/2026 Published by Pharma Biz

Someone suddenly becomes confused, slurs their words, or their limbs go weak or shaky — this could be a stroke,... Read more

Category: Uncategorized

Tags: #Corporate Wellness

When AI commoditizes execution: Shifting focus from building to problem framing

13/08/2026 Published by Pharma Biz

The rapid proliferation of generative AI algorithms and agentic coding platforms is accelerating the feasibility of the "solo builder" model.... Read more

Category: Uncategorized

Tags: #Capability Development

The Readiness Triad: Evaluating organizational execution capacity before strategy rollout

13/08/2026 Published by Pharma Biz

Corporate leadership teams frequently demonstrate exceptional proficiency in strategic design. They rigorously analyze market dynamics, evaluate competitive trade-offs, and construct... Read more

Category: Uncategorized

Tags: #Human Resources

Intellectual Property Enforcement: Eli Lilly Files Federal Lawsuits Against Six Entities Over Illegal Commercialization of Experimental Obesity Drug Retatrutide

12/08/2026 Published by Pharma Biz

Key Development American biopharmaceutical major Eli Lilly and Company (NYSE: LLY) officially announced on August 12, 2026, that it has... Read more

Category: Uncategorized

Tags: #Global Trends

Rare Disease Licensing Agreement: Mereo BioPharma and Sentynl Therapeutics Execute Up to $475 Million Deal for Oral AATD-LD Candidate Alvelestat

12/08/2026 Published by Pharma Biz

Key Development UK-based biopharmaceutical firm Mereo BioPharma and Sentynl Therapeutics (a rare disease commercial subsidiary of Indian pharmaceutical group Zydus... Read more

Category: Uncategorized

Tags: #Global Trends